Skip to main content
Caplight Logo









SpayVac for Wildlife

SpayVac for Wildlife

Private
Madison, WisconsinHealthcare & Life Scienceshttps://spayvac.com/

Last Round

Seed

Jul 1, 2025

Total Funding Raised

$1.37M

Company Overview

SpayVac for Wildlife is a biotechnology company that develops single-dose, long-lasting immunocontraceptive vaccines for humane animal population control.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

immunocontraceptive vaccinewildlife managementanimal fertility controlnon-lethal population controlwildlife birth controlliposome deliverybiotechnologyanimal population managementvaccine developmentfield trial designbiomanufacturingcontract development and manufacturing organizationCDMOenvironmental protection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SpayVac for Wildlife Comparables

Compare SpayVac for Wildlife with similar companies based on industry and business-model similarity.

SpayVac for Wildlife comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NgenLab
73%
Epivara Inc.
67%
Zoetis Inc.
65%

SpayVac for Wildlife Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 1, 2025
GrantApr 11, 2023
SeedJun 28, 2022

Key People

Founding team and executive leadership

Thomas D'Orazio

Board Member CEO

Executive Team

SpayVac for Wildlife Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 20, 2025

    Tina Lloren appointed as Director of Operations.

  • Jun 28, 2022

    BrightStar Wisconsin Foundation participated in the seed round.

SpayVac for Wildlife Filings

Explore SEC and related filing metadata, where available.

SpayVac for Wildlife filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SpayVac for Wildlife's valuation, stock price, and market status.

Is SpayVac for Wildlife a public or private company?

SpayVac for Wildlife is a private company.

What is the current stock price of SpayVac for Wildlife?

SpayVac for Wildlife is a private company with no public stock price. No recent secondary market data is available.

How much is SpayVac for Wildlife worth (valuation)?

Valuation information for SpayVac for Wildlife is not publicly available.

Can I buy SpayVac for Wildlife stock?

SpayVac for Wildlife shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SpayVac for Wildlife's last funding round?

SpayVac for Wildlife's most recent funding round was Seed on July 1, 2025.

Who are the main investors in SpayVac for Wildlife?

Key investors in SpayVac for Wildlife include Serra Ventures, Central Texas Angel Network, US Department of the Interior's Bureau of Land Management.

Will SpayVac for Wildlife IPO soon?

No public IPO plans have been announced for SpayVac for Wildlife.

How can I track SpayVac for Wildlife secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SpayVac for Wildlife's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMadison, Wisconsin
Employee Range4
Year Founded2017
Last FundingJul 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?